These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 19059120)
1. Profound thrombocytopenia with glycoprotein IIb/IIIa inhibitors plus heparin for pump thrombus. Blais DM; Sun B; Vesco P; Louis LB; Sai-Sudhakar C; Firstenberg MS J Heart Lung Transplant; 2008 Dec; 27(12):1361-2. PubMed ID: 19059120 [No Abstract] [Full Text] [Related]
2. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735 [TBL] [Abstract][Full Text] [Related]
3. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173 [TBL] [Abstract][Full Text] [Related]
4. Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis. Al-Quthami AH; Jumean M; Kociol R; Pham DT; Kiernan M; DeNofrio D; Kapur NK Circ Heart Fail; 2012 Jul; 5(4):e68-70. PubMed ID: 22811551 [No Abstract] [Full Text] [Related]
6. Left ventricular assist device pump thrombosis: is there a role for glycoprotein IIb/IIIa inhibitors? Bellumkonda L; Subrahmanyan L; Jacoby D; Bonde P ASAIO J; 2014; 60(1):134-6. PubMed ID: 24335386 [TBL] [Abstract][Full Text] [Related]
7. Increased platelet glycoprotein IIb/IIIa activation precedes continuous-flow left ventricular assist device pump thrombosis events. Weiland M; Schuitema J; Jovinge S; Lee S Thromb Res; 2021 May; 201():143-146. PubMed ID: 33798825 [No Abstract] [Full Text] [Related]
8. Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury. Bienvenu LA; Maluenda A; McFadyen JD; Searle AK; Yu E; Haller C; Chaikof EL; Peter K; Wang X Circ Res; 2020 Oct; 127(9):1211-1213. PubMed ID: 32806996 [No Abstract] [Full Text] [Related]
9. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW; Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152 [TBL] [Abstract][Full Text] [Related]
10. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. Stone GW; Ware JH; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Feit F; Colombo A; McLaurin BT; Cox DA; Manoukian SV; Fahy M; Clayton TC; Mehran R; Pocock SJ; JAMA; 2007 Dec; 298(21):2497-506. PubMed ID: 18056903 [TBL] [Abstract][Full Text] [Related]
11. Pump Thrombosis: A Limitation of Contemporary Left Ventricular Assist Devices. Kapur NK; Vest AR; Cook J; Kiernan MS Curr Probl Cardiol; 2015 Dec; 40(12):511-40. PubMed ID: 26542611 [TBL] [Abstract][Full Text] [Related]
12. Platelet PlA2 Polymorphism and the risk for thrombosis in heparin-induced thrombocytopenia. Harris K; Nguyen P; Van Cott EM Am J Clin Pathol; 2008 Feb; 129(2):282-6. PubMed ID: 18208809 [TBL] [Abstract][Full Text] [Related]
13. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors. Dobesh PP; Latham KA Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. Thomas MD; Wood C; Lovett M; Dembo L; O'Driscoll G J Heart Lung Transplant; 2008 Aug; 27(8):925-7. PubMed ID: 18656810 [TBL] [Abstract][Full Text] [Related]